Amy Jo Sterling

Array ( [id] => 448090 [patent_doc_number] => 07250169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Anti-tumor activity of Ea-4-peptide of pro-IGF-1' [patent_app_type] => utility [patent_app_number] => 10/647732 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5096 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250169.pdf [firstpage_image] =>[orig_patent_app_number] => 10647732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415370 [patent_doc_number] => 07279554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Notch receptor ligands and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/644548 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16550 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279554.pdf [firstpage_image] =>[orig_patent_app_number] => 10644548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061003 [patent_doc_number] => 20050003364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Secreted factors' [patent_app_type] => utility [patent_app_number] => 10/638141 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27690 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003364.pdf [firstpage_image] =>[orig_patent_app_number] => 10638141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 526405 [patent_doc_number] => 07183254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment' [patent_app_type] => utility [patent_app_number] => 10/623189 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9066 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183254.pdf [firstpage_image] =>[orig_patent_app_number] => 10623189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397783 [patent_doc_number] => 20040018544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family' [patent_app_type] => new [patent_app_number] => 10/622407 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46607 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018544.pdf [firstpage_image] =>[orig_patent_app_number] => 10622407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432140 [patent_doc_number] => 20040162237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Use of lp82 to treat body weight disorders' [patent_app_type] => new [patent_app_number] => 10/466695 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20385 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162237.pdf [firstpage_image] =>[orig_patent_app_number] => 10466695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991399 [patent_doc_number] => 20050090436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Human tumor necrosis factor receptors TR21 and TR22' [patent_app_type] => utility [patent_app_number] => 10/620562 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 86423 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090436.pdf [firstpage_image] =>[orig_patent_app_number] => 10620562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7354907 [patent_doc_number] => 20040048799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Combination therapy using a TNF binding protein for treating TNF-mediated diseases' [patent_app_type] => new [patent_app_number] => 10/622383 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22309 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048799.pdf [firstpage_image] =>[orig_patent_app_number] => 10622383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7349307 [patent_doc_number] => 20040047863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Combination therapy using a TNF binding protein for treating TNF-mediated diseases' [patent_app_type] => new [patent_app_number] => 10/621783 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22306 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047863.pdf [firstpage_image] =>[orig_patent_app_number] => 10621783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 545883 [patent_doc_number] => 07164004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Human tumor necrosis factor TR20 and methods based thereon' [patent_app_type] => utility [patent_app_number] => 10/618797 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 103273 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/164/07164004.pdf [firstpage_image] =>[orig_patent_app_number] => 10618797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252441 [patent_doc_number] => 20050074855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'High affinity fusion proteins and therapeutic and diagnostic methods for use' [patent_app_type] => utility [patent_app_number] => 10/610452 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9970 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074855.pdf [firstpage_image] =>[orig_patent_app_number] => 10610452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483712 [patent_doc_number] => 07220838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Antibodies that specifically bind hedgehog-derived polypeptides' [patent_app_type] => utility [patent_app_number] => 10/460594 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 132 [patent_no_of_words] => 51255 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220838.pdf [firstpage_image] =>[orig_patent_app_number] => 10460594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 900482 [patent_doc_number] => 07339028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-04 [patent_title] => 'Mahoganoid polypeptides, and related compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/456881 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 12801 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/339/07339028.pdf [firstpage_image] =>[orig_patent_app_number] => 10456881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406475 [patent_doc_number] => 20040024192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => '19 human secreted proteins' [patent_app_type] => new [patent_app_number] => 10/443622 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46302 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024192.pdf [firstpage_image] =>[orig_patent_app_number] => 10443622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363399 [patent_doc_number] => 20040014948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Single-chain antagonist polypeptides' [patent_app_type] => new [patent_app_number] => 10/444691 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 40059 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014948.pdf [firstpage_image] =>[orig_patent_app_number] => 10444691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448912 [patent_doc_number] => 20040067504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Adipocyte complement related protein zacrp8' [patent_app_type] => new [patent_app_number] => 10/423582 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 49345 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067504.pdf [firstpage_image] =>[orig_patent_app_number] => 10423582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355981 [patent_doc_number] => 20040013664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Tumor necrosis factor receptors 6 alpha & 6 beta' [patent_app_type] => new [patent_app_number] => 10/418242 [patent_app_country] => US [patent_app_date] => 2003-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 121926 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013664.pdf [firstpage_image] =>[orig_patent_app_number] => 10418242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 421777 [patent_doc_number] => 07273707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-25 [patent_title] => 'Method of identifying a modulator of a LTβR complex signaling pathway' [patent_app_type] => utility [patent_app_number] => 10/361270 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6187 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273707.pdf [firstpage_image] =>[orig_patent_app_number] => 10361270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797472 [patent_doc_number] => 20030176346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity' [patent_app_type] => new [patent_app_number] => 10/356191 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7126 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176346.pdf [firstpage_image] =>[orig_patent_app_number] => 10356191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852287 [patent_doc_number] => 20030144490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Extended cDNAs for secreted proteins' [patent_app_type] => new [patent_app_number] => 10/319763 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 62028 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144490.pdf [firstpage_image] =>[orig_patent_app_number] => 10319763 [rel_patent_id] =>[rel_patent_doc_number] =>)